https://biotechmorning.com/news/mrna-vaccine-no-freezer-ai-lipid-nanoparticles Biotech Morning en 2026-09-29T14:18:49.465Z The mRNA Vaccine That Doesn't Need a Freezer https://biotechmorning.com/news/novo-nordisk-2-6-billion-hengrui-preclinical-glp1 Biotech Morning en 2026-09-29T14:18:05.315Z Novo Just Paid $2.6 Billion for a Drug Nobody's Tested in Humans https://biotechmorning.com/news/astrazeneca-2-billion-summit-therapeutics-ivonescimab Biotech Morning en 2026-09-29T14:17:18.467Z AstraZeneca Just Wrote a $2 Billion Check for a Drug It Doesn't Own https://biotechmorning.com/news/novartis-avidity-12-billion-bet Biotech Morning en 2026-09-29T14:16:27.291Z Novartis Bet $12 Billion on a Platform. Then the Data Came In. https://biotechmorning.com/news/roche-obesity-antibody-emugrobart-discontinued Biotech Morning en 2026-09-29T14:15:41.675Z Roche's Muscle Plan for Obesity Just Hit a Wall https://biotechmorning.com/news/telix-itm-radiopharmaceutical-acquisition Biotech Morning en 2026-09-29T14:14:56.464Z Telix Just Bet $2.35 Billion That Radioactive Drugs Are the Future https://biotechmorning.com/news/merck-discontinues-recarbrio-antibiotic-superbug-crisis Biotech Morning en 2026-09-29T14:14:13.725Z The Antibiotic That Hospitals Need but Merck Won't Make Anymore https://biotechmorning.com/news/genetics-heart-drugs-pelacarsen-ziltivekimab-fail Biotech Morning en 2026-09-29T14:13:29.654Z Genetics Said These Heart Drugs Should Work. The Patients Disagreed. https://biotechmorning.com/news/novartis-remibrutinib-ms-trial-results Biotech Morning en 2026-09-29T14:12:42.735Z The MS Drug That Doesn't Kill Your Immune Cells (It Just Calms Them Down) https://biotechmorning.com/news/merck-scibrunch-kras-g12d-deal Biotech Morning en 2026-09-29T14:11:57.811Z Merck Just Paid $400M for a Drug That Doesn't Exist Yet https://biotechmorning.com/news/kodiak-sciences-daybreak-eye-drug-comeback Biotech Morning en 2026-09-29T14:11:09.284Z The Eye Drug That Went From Dead to Stock-Doubling Overnight https://biotechmorning.com/news/gene-editing-child-deaths-china-oversight Biotech Morning en 2026-09-28T14:14:05.410Z Gene Editing's Darkest Day: Two Children Dead, and China Stayed Quiet https://biotechmorning.com/news/telix-itm-isotope-acquisition-radiopharmaceutical-supply Biotech Morning en 2026-09-28T14:13:28.924Z Telix Just Spent $2.35 Billion to Own the Fuel Behind Cancer's Hottest Weapons https://biotechmorning.com/news/prime-medicine-prime-editing-aatd-ind-clearance Biotech Morning en 2026-09-28T14:12:40.217Z The Gene Editor That Rewrites Your DNA Like a Word Processor https://biotechmorning.com/news/gotistobart-nearly-doubles-survival-squamous-nsclc Biotech Morning en 2026-09-28T14:11:46.856Z The Lung Cancer Drug That Nearly Doubled Survival Time https://biotechmorning.com/news/roche-simcere-zaiming-trispecific-antibody-deal Biotech Morning en 2026-09-28T14:11:03.790Z Roche Just Bet $1.5B on a Drug That Hasn't Touched a Human Yet https://biotechmorning.com/news/brelovitug-hepatitis-delta-phase-3-azure Biotech Morning en 2026-09-28T14:10:16.187Z The Liver Disease Nobody Talks About Just Got a New Weapon https://biotechmorning.com/news/eli-lilly-once-weekly-insulin-approval Biotech Morning en 2026-09-28T14:09:31.960Z The End of 300 Needles a Year https://biotechmorning.com/news/cancer-therapy-curing-lupus-adicet-car-t Biotech Morning en 2026-09-28T14:08:52.264Z The Cancer Therapy That's Curing Lupus https://biotechmorning.com/news/astrazeneca-wainua-attr-cm-phase-3-failure Biotech Morning en 2026-09-28T14:08:05.079Z AstraZeneca's Billion-Dollar Heart Drug Just Hit a Wall Nobody Saw Coming